META ADS · CREATIVE STRATEGY · CREATIVE PRODUCTION

We took their return on ad spend from 1.8x to 2.5x, while scaling spend past $500k a month.

The engine behind it: 70 to 80 brand-new ad ideas a month, in a category most people quietly don't trust.

Clinical probiotics / gut health · premium DTC + retail · US · Meta creative strategy + production

1.8x → 2.5x

return on ad spend (up ~39%)

$500k+ /mo

ad spend at this scale

70–80

brand-new ad ideas a month

The situation

Probiotics are a category people quietly don't trust. The supplement aisle is full of pills making big promises, most of them junk, so the default reaction to any gut-health ad is a shrug.

Seed is the opposite of junk. It's a clinical, research-backed synbiotic. But that creates its own problem. The science is real, and the science is hard to sell in three seconds of scrolling. Nobody stops for a strain count. So the challenge was getting a distrusted category to pay attention, and getting people to believe a premium product is worth it.

The winner we scaled

The breakout was the bluntest one. Two capsules, a microbiome-blue background, three words: Poop Every Day. No hedging, no science lecture, just the outcome people want, with a small line underneath on bloating and gas.

It scaled the hardest because it said the quiet part out loud. And it kept working because the promise is something you notice within days, not a claim you have to take on faith.

$50–200 to make a new version of a winner, vs $500–2,000 for a fresh shoot.

What we found

The science didn't sell. The outcome did. People don't buy "24 strains, clinically studied." They buy "poop every day" and "no bloat after meals." So we dropped the lecture and led with the blunt, slightly funny result people actually feel.

And because trust was the real barrier, we leaned on proof people would believe. Seed landing in Target nationwide quietly says "this is legit" without making a single health claim. In a doubted category, that kind of proof does more than any ingredient list.